How to buy Pfizer shares

Global stock markets soared in response to the news that American pharmaceuticals company Pfizer (PFE) has developed a vaccine, tested on 43,500 people, which it claims is 90% effective.

On the day of the announcement, Pfizer's share price rose 15%, before falling back and closing 7% up on the previous day. Other industries reacted positively to the news, with global economic hopes seemingly pinned on the vaccine.

Our top picks for where to buy Pfizer shares

Best for 0% commission stocks

Finder Award

Go to site

Capital at risk. T&Cs apply.

Copy picks from top traders

Commission-free trades
Fractional shares
Get dividend payments

Best for uninvested cash

Go to site

Capital at risk. T&Cs apply.

Up to 8.5% interest on uninvested cash

11,000+ stocks & ETFs
Commission-free investing
Advanced trading tools

Best for fractional shares

Go to site

Capital at risk. T&Cs apply.

Earn 4.5% on uninvested funds

Commission-free trades
Fractional shares
5,400+ stocks/ETFs

Pfizer stock chart

Fees calculator for buying Pfizer shares with popular apps

Find the cheapest way to buy Pfizer shares with our calculator. Bear in mind that both exchange rates and share prices fluctuate in real time, so the costs estimated here are just a guide (refer to platforms themselves for availability and exact pricing).

Quantity of shares

Platform	Finder Score	Account fee	Min. initial deposit	Trade cost	Link
	9 Excellent	£0	$100	£1,661.22	Go to siteCapital at risk
	9.1 Excellent	£0	£0	£1,665.18	Go to siteCapital at risk
	9 Excellent	From £0	£0	£1,660.40	Go to siteCapital at risk
	8.8 Great	£0	£0	£1,649.35	Go to siteCapital at risk
	9.2 Excellent	£0	£0	£1,657.10	Go to siteCapital at risk
	8.5 Great	£0 (0.45% for funds)	£1	£1,677.30	Go to siteCapital at risk

Full comparison of share dealing platforms

Alternative ways to invest in Pfizer

• Via a fund
• Via an S&P 500 ETF

Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Pfizer), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.

Pfizer is a major part of the NYSE, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

ETF	Icon	1-year performance (to May. '25)	5-year performance (to May. '25)	Link
Invesco S&P 500 ETF (SPXP)		7.36%	103.96%	Invest Capital at risk
Xtrackers S&P 500 Swap ETF 1C (XSPX)		7.31%	103.42%	Invest Capital at risk
iShares Core S&P 500 ETF USD (Acc) (CSP1)		7.31%	102.05%	Invest Capital at risk
HSBC S&P 500 ETF (HSPX)		6.07%	90.28%	Invest Capital at risk

Boost your investment IQ!

Subscribe now for market insights, expert advice and a chance to win £800! (T&Cs)

Sign uploading

Winners | Emails | Unsubscribe | Privacy

Is it a good time to buy Pfizer stock?

Review technicals and fundamentals to help you determine if now's a good time for you to invest.

Technical analysis

View Pfizer's price performance, share price volatility, historical data and technicals.

• Quick verdict
• Historical data

Invest in Pfizer shares

Finder AwardFree Trades

• Over 5,500+ stocks from 20 exchanges
• Free to open an account
• Commission-free trading

Go to site

Capital at risk

Is Pfizer under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Pfizer P/E ratio, PEG ratio and EBITDA.

• P/E ratio
• Pfizer PEG ratio
• Pfizer EBITDA

Frequently asked questions

• Does Pfizer pay dividends?

  • Dividend yield
  • Forward yield
  • Payout ratio

  Dividend yield: 7.52% of stock value

  Forward annual dividend yield: 7.52% of stock value

  Dividend payout ratio: 52.96% of net profits

  Pfizer has recently paid out dividends equivalent to 7.52% of its share value annually.

  Pfizer has paid out, on average, around 52.96% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 7.52% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 7.52% return on their shares, in the form of dividend payments. In Pfizer's case, that would currently equate to about 1.69 per share.

  Pfizer's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

  Pfizer's next dividend payout is expected around 12 June 2025. To be eligible for the latest dividend you would need to have been a shareholder at 8 May 2025 (the "ex-dividend date").

  Pfizer's dividend yield is perhaps best considered in relation to those of similar companies.

  • Gilead Sciences (GILD.US): 3.07% (3.07% forward annual dividend yield)
  • Johnson-and-Johnson (JNJ.US): 3.37% (3.37% forward annual dividend yield)
  • Abbott Laboratories (ABT.US): 1.77% (1.77% forward annual dividend yield)
  • IDEXX Laboratories (IDXX.US): (does not pay dividend)
  • GlaxoSmithKline (GSK.LSE): 4.64% (4.64% forward annual dividend yield)
  • AstraZeneca (AZN.LSE): 2.34% (2.34% forward annual dividend yield)

• When does the fiscal year end for Pfizer?

  Pfizer's fiscal year ends in December.

• Where is Pfizer based?

  Pfizer's address is: 66 Hudson Boulevard East, New York, NY, United States, 10001-2192

• Have Pfizer's shares ever split?

  Pfizer's shares were split on a 1054:1000 basis on 16 November 2020. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1054 shares. This wouldn't directly have changed the overall worth of your Pfizer shares – just the quantity. However, indirectly, the new 5.1% lower share price could have impacted the market appetite for Pfizer shares which in turn could have impacted Pfizer's share price.

• How to sell Pfizer shares

  It's as easy to sell Pfizer as it is to buy! Here's how to sell Pfizer shares that you already own.

  1. Open your investment app. If you've got one with desktop access, you can log in online
  2. Go to your portfolio. This should be in the main menu
  3. Find your shares. You may be able to search your portfolio
  4. Choose how many you'd like to sell. You'll be able to review the price and see how much you'll receive
  5. Sell your Pfizer shares. Your investment platform will let you know when your shares are sold

• Can you buy Pfizer shares with a debit card?

  Most dealing providers will let you use your debit card to top up your account and buy shares. The main ways are with a debit card, bank transfer or with Apple/Google Pay.

• What's the easiest way to buy Pfizer shares?

  The easiest way to get hold of some Pfizer shares is to sign up for a share trading app and place a market order or basic order. This type of order tells the platform that you're interested, so it'll try to execute it as quickly as it can. It could take some time for the order to go through, especially if there's a lot of volatility in Pfizer shares.

• Do you need to complete a W8-BEN form if you want to invest in Pfizer

  Yes. When you investing in a US stock, you need to complete a W8-BEN form to minimise your tax liability. Whether these are automatically handled for you depends on your broker, so it would be a good idea to check with them directly.

• What is the key financial information for Pfizer?

  Pfizer financials

  Revenue TTM	$62.5 billion
  Operating margin TTM	36.46%
  Gross profit TTM	$46.5 billion
  Return on assets TTM	4.64%
  Return on equity TTM	9.06%
  Profit margin	12.62%
  Book value	$15.56
  Market capitalisation more info button	$134.9 billion

  TTM: trailing 12 months

Ready to compare platforms?

Get started